Top

BMC Public Health

Published in:

Open Access 01-12-2022 | Care | Research article

Structural violence and the need for compassionate use of methadone in Mexico

Authors: Martha Romero-Mendoza, Ingris Peláez-Ballestas, Ariagor Manuel Almanza-Avendaño, Emilia Figueroa

Published in: BMC Public Health | Issue 1/2022

Abstract

Background

Epidemiological data from Mexico have documented an increase in heroin use in the last decade. However, there is no comprehensive care strategy for heroin users, especially those who have been accused of a crime. The objective of this study was to describe the heroin and methadone use of intravenous heroin users of both sexes who have been in jail, to offer evidence for the formulation of health policy.

Methods

This study used an ethnographic approach, with open-ended interviews carried out from 2014 to the present. Heroin users of both sexes attending a private methadone clinic in Mexico City were invited to participate. The sample was non-probabilistic. All interviews were audiotaped and transcribed, and narratives were analyzed using thematic analysis.

Results

Participants in this study were 33 users of heroin, two of them women, who had been in prison. They ranged in age from 33 to 62 years, had used heroin for a period of 13–30 years, and were from three states: Michoacan, Oaxaca, and Mexico City. Three principal categories of analysis were structured: 1. Pilgrimage for help (dynamics of the drama of suffering, pain, and time through health care spaces); 2) methadone use as self-care; and 3) accessibility to methadone treatment. The impossibility of access to methadone treatment is a condition which motivates users in their journey. The dynamics of methadone use are interpreted as a form of self-care and care to avoid substance use. Reducing the psychological, physical, and harmful effects of the substance allows them to perform daily activities. The inability to access treatment leads to a significant effect on users who experience structural violence.

Conclusion

Compassionate methadone treatment and holistic attention should be considered as a way to meet patients’ needs and mitigate their suffering, based on public health policy that allows for human rights-based care.

Available only for authorised users

Strang J, Volkow N, Degenhardt L, Hickman M, Johnson K, Koob G, Marshall B, Tyndall M, Walsh S. Opioid Use disorder. Nat Rev Dis Primers. 2020;6(3):1–28.

Eastwood B, Strang J, Marsden J. Continuous opioid substitution treatment over five years: Heroin use trajectories and outcomes. Drug Alcohol Depend. 2018;188:200–8. https://doi.org/10.1016/j.drugalcdep.2018.03.052.CrossRefPubMed

Wakeman S. Diagnosis and treatment of opiod use disorder in 2020. JAMA. 2020;323(20):2082–3.CrossRef

Romero MM, Medina MME, González H, Vásquez J, Armas G. Guía para el uso de metadona en usuarios adultos con VIH dependientes de la heroína intravenosa. Mexico: Secretaría de Salud.: Instituto Nacional de Psiquiatría, CENSIDA; 2016.

Mazhnaya A, Bojko M, Marcus R, Filippovych S, Islam Z, Dvoriak S, Altice F. In their own voices: breaking the vicious cycle of addiction, treatment and criminal justice among people who inject drugs in Ukraine. Drugs. 2016;23(2):163–75. https://doi.org/10.3109/09687637.2015.1127327.CrossRefPubMed

Fox A, Maradiaga J, Weiss L, Sánchez J, Starrels J, Cunningham CH. Release from incarceration, relapse to opioid us and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorders. Addict Sci Clin Pract. 2015;10(1):2. https://doi.org/10.1186/s13722-014-0023-0.CrossRefPubMedPubMedCentral

Gisev N, Degenhardt L, Larney S, Larance B, Gibson A, Kimber J, Burns L. A comparative study of opiod substitution therapy utilization among opioid-dependent men and women. Drug Alcohol Rev. 2014;33(5):499–505. https://doi.org/10.1111/dar.12151.CrossRefPubMed

Ospina A. Itinerarios de adversidad. Biografías de uso de drogas, estilos de vida y ambientes de riesgo al VIH en varones inyectores de Tijuana, Cd. Juárez y Hermosillo, México. ed. El Colegio de México: Centro de Estudios Demográficos y Ambientales; 2016.

Morales M, Rafful C, Gaines TL, et al. Factors associated with extrajudicial arrest for syringe possession: results of a department-wide survey of municipal police in Tijuana. Mexico BMC Int Health Hum Rights. 2018;1(18):1–36. https://doi.org/10.1186/s12914-018-0175-1.CrossRef

10.

Fleiz BC, Domínguez GM, Villatoro VJA, Vázquez QF, Zafra ME, Sánchez RR, Reséndiz EE, Bustos GM, Medina MME. Cuqueando la Chiva: Contextos del consumo de heroína en la frontera norte de México. México: INPRFM; 2019.

11.

Flores S. Oaxaca, quinto consumidor de heroína en el país. 2016. https://www.tvbus.tv/web/2016/11/23/oaxaca-quinto-consumidor-heroinaen-pais. Accessed 17 June 2020.

12.

Bosch L. Campos de amapola. Antes de esto. Una novela sobre el narcotráfico en México. México: Océano; 2012.

13.

UNODC. El gobierno de México y la UNDOC lanzan segundo informe de monitoreo de cultivos de amapola en México. 2018. https://www.unodce.org/mexicoandcentralamerica/es/webstories/2019/el_gobierno_de_mexico_y_la_undoc.html. Accessed 28 Dec 2021.

14.

Álvarez RI. Ruralidad, narcotráfico y violencia. Un modelo para armar. In: Porter JM, Aviña A. Introducción. La violencia toma lugar. Programa Noria para México y América Central. 2020. https://noriaresearch.com/ruralidad-narcotrafico-y-violencia-un-modelo-para-armar/. Accessed 30 Dec 2021.

15.

Curry A. Violencia y capitalismo aguacatero en Michoacán. In: Porter JM y Aviña A. Capítulo 4. Programa Noria para México y América Central. 2021. http://noria-research.com/violencia-y-capitalismo-aguacatero-en-michoacan/. Accessed 30 Dec 2021.

16.

Linthicum K. No solo drogas Los cárteles de México están peleando por aguacates. Los Angeles Times. 2019. http://www.latimes.com/espanol/mexico/articulo/2019-11-21/mexico-cartel-violencia-aguacates. Accessed 30 Dec 2021.

17.

Tamariz G. Oaxaca. La milpa en temporada de drogas. En: Capítulo 5 de la serie La violencia toma lugar. Noria Research. México: México & Central América Program; 2021. http://norareseach.com/oaxaca-la-milpa-en-temporada-de-drogas. Accessed 30 Dec 2021.

18.

Frissard P, Farfán MC, Lecour GR. Untangling Opium Poppy from violence. Noria Opium Project. 2021. http://www.academia.edu/49334976/Policy_Paper_Untangling_Opium_Poppy_from_Violence_in_Mexico. Accessed 20 Dec 2021.

19.

McGowan CR, Viens AM, Harris M, Rhodes T. Risk environments and the ethics of reducing drug related harms. Am J Bioeth. 2017;17(2):1–3. https://doi.org/10.1080/15265161.2017.1388870.CrossRef

20.

Cortés C, Uribe C, Vásquez R. Etnografía clínica y narrativas de enfermedad de pacientes afectados con trastorno obsesivo compulsivo. Revista colombiana de psiquiatría. 2005;34(2):190–219.

21.

Pérez GA. La etnografía como método integrativo. Revista colombiana de psiquiatría. 2012;41(2):42–428.

22.

Hammer D, Wildasvky A. La entrevista de final abierto. Aproximación a una guía operativa. Historia y fuente Oral 4, Entrevistar ¿para qué? 1990;1(1):23–61.

23.

Mondragón BL. Consentimiento informado: Una praxis dialógica para la investigación. Rev Invest Clin. 2009;61(1):2–14.

24.

Gutiérrez A. Las metáforas del cuerpo ¿Más allá de la naturaleza o con la naturaleza? Revista del Colegio de San Luis. 2013;3(5):258–86.

25.

Heckarton D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Prob. 1997;4(2):174–99.

26.

Riesmann CK. Narrative methods for the human sciences. Thousand Oaks: Sage Publications; 2008.

27.

Creswell J, Poth CH. Qualitative Inquiry & Research Design. Choosing among five approaches. Thousand Oaks: Sage Publications; 2018.

28.

Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77. https://doi.org/10.1191/1478088706qp063oa.CrossRef

29.

Clarke V, Braun V. Thematic analysis. J Posit Psychol. 2017;12(3):297–8. https://doi.org/10.1080/17439760.2016126213.CrossRef

30.

Shenton AK. Strategies for ensuring trustworthiness in qualitative research projects. Educ Inf. 2004;22(2):63–75. https://doi.org/10.3233/EFI-2004-221201.CrossRef

31.

Borges G, Wang P, Medina MME, Lara C, Chiu W. Delay of first treatment of mental and substance use disorders in Mexico. Am J Public Health. 2007;97:1638–43. https://doi.org/10.2105/AJPH.2006.090985.CrossRefPubMedPubMedCentral

32.

Peláez BI, Romero MM, Ramos LL, Caballero R, Garduño A, Burgos VR. Illness Trajectories in Mexican Children with Juvenile idiopathic arthritis and their parents. Rheumatology. 2006;1(1):1–5.

33.

Peláez BI, Pérez TR, Acéves ÁJ, Burgos VR. “Not-Belonging”: Illness Narratives of Mexicans patients with Ankylosing Spondylitis. Medical Anthropology: Cross-Cultural Studies in Health and Illness. 2013;32(5):487–500.CrossRef

34.

Lozano VI, Romero MM, Marin NR. Violence narratives of Mexican women treated in mutual-aid residential centers for addiction treatment. Subst Abuse Treat Prev Policy. 2016;11(39):1–10.

35.

Ning AM. Games of truth: rethinking conformity and resistance in narratives of heroin recovery. Med Anthropol. 2005;24(4):349–82. https://doi.org/10.1080/01459740500334649.CrossRefPubMed

36.

Richert T, Johnson B. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden. Harm Reduct J. 2015;1(12):2–14. https://doi.org/10.1186/s12954-015-0037-2.CrossRef

37.

Foucault M. La hermenéutica del sujeto. 2nd ed. México: Fondo de Cultura Económica; 2002.

38.

Muñoz E. Reflexiones sobre el cuidado de sí como categoría de análisis en salud. Salud Colectiva. 2009;5(3):391–401.CrossRef

39.

Van HMC, Bingham T. A qualitative study of prescribing doctor experiences of Methadone Maintenance Treatment. Int J Ment Heal Addict. 2014;1(12):227–42. https://doi.org/10.1007/s11469-013-9436-3.CrossRef

40.

Yarborough BJ, Stumbo SP, McCarty D, Mertens J, Weisner C, Green CA. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis. Drug Alcohol Depend. 2016;160(1):112–8. https://doi.org/10.1016/j.drugalcdep.2015.12.031.CrossRefPubMedPubMedCentral

41.

Lin C, Wu Z, Detels R. Opiate users perceived barriers against attending methadone maintenance therapy: A qualitative study in China. Subst Use Misuse. 2011;46(9):1190–8. https://doi.org/10.3109/10826084.2011.561905.CrossRefPubMedPubMedCentral

42.

World Health Organization. The right to health. 2013. http://www.ohchr.org/Documents/Publications/Factsheet31.pdf. Accessed 20 June 2020.

43.

McNeil R, Kerr T, Anderson S, Maher L, Keewatin C, Milloy M, Wood E, Small W. Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study. Soc Sci Med. 2015;133(1):168–76. https://doi.org/10.1016/j.socscimed.2015.04.008.CrossRefPubMedPubMedCentral

44.

Naegle M, Mitchell A, Flinter M, Dunphy L, Vanhook P, Delaney K. Opioid misuse epidemic: addressing opioid prescribing and organization initiatives for holistic, safe and compassionate care. American Academy of Nursing on Policy. 2017;65(4):477–9. https://doi.org/10.1016/j.outlook.2017.07.001.CrossRef

45.

Farmer PE, Nizeye B, Stulac S, Keshavjee S. Structural violence and clinical medicine. PLoS Med. 2006;3(10):1686–91. https://doi.org/10.1371/journal.pmed.0030449.CrossRef

46.

Moradi G, Farnia M, Shokoohi M, Shanbazi M, Moazen B, Rahmani K. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran. Int J Health Policy Manag. 2015;4(9):583–9. https://doi.org/10.15171/ijhpm.2015.60.CrossRefPubMedPubMedCentral

47.

Chandler A, Whittaker A, Williams N, McGorn K, Cunningham-Burley S, Mathews G. Mother´s little helper? Contrasting accounts of bensodiazepine and methadone use among drug-dependent parents in the UK. Drug. 2014;21(6):470–5. https://doi.org/10.3109/09687637.2014.930814.CrossRef

48.

Demirci J, Bogen D, Klionsy Y. Substance abuse. 2015;1(36):203–8. https://doi.org/10.1080/08897077.2014.902417.CrossRef

49.

Minozzi S, Amato L, Bellisario C, Ferri M, Davoli M. Maintenance agonist treatments for opiate-dependent pregnant women. Cochrane Database of Syst Rev. 2013;1(5):1465–858. https://doi.org/10.1002/14651858.CD006318.pub3.CrossRef

50.

Dalby L, Kerr T. PTSD and opioid use: implications for intervention and policy. Subst Abuse Treat Prev Policy. 2020;1(15):1–22. https://doi.org/10.1186/s13011-020-00264-8.CrossRef

51.

García CI. Consideraciones legales y bioéticas sobre uso compasivo de medicamentos. Trabajo práctico del curso de especialista en derecho sanitario y bioética. España: Colegio de Abogados de Murcia; 2005.

52.

Muruzabal L. Medicamentos extranjeros y uso compasivo de medicamentos. Boletín de Información Farmacoterapéutica de Navarra. 2005;1(13):4–20.

53.

BOE. RD 223/2004, de 6 de febrero, por el que se regulan los ensayos clínicos con medicamentos. 2004. https://www.boe.es/eli/es/rd/2004/02/06/223/con. Accessed 19 June 2020.

54.

BOE. Ley 29/2006, de 26 de julio, de Garantías y Uso Racional de los Medicamentos y Productos Sanitarios. 2006. https://www.boe.es/buscar/pdf/2006/BOE-A-2006-13554-consolidado.pdf. Accessed 18 June 2020.

55.

Whitaker EM, Atkinson PA. Reflexivity. In: Sage Research Methods Foundations. London: Sage Publishing. 2019; https://doi.org/10.4135/9781546421036819785.

56.

Lumsden K, Bradford J, Goode J. Chapter 4: Emotions and reflexivity in social research. In: Lumsden: Reflexivity: theory method and practice. London: Routledge; 2019. https://doi.org/10.4324/9781315692319-5.

57.

Passegi M. Reflexividad narrativa: “vida, experiencia vivida y ciencia.” Márgenes Revista de educación de la Universidad de Málaga. 2020;1(3):91–109. https://doi.org/10.24310/mgnmar.v1i3.9504.CrossRef

58.

Csete J. The elusive search for rights-centered public health approaches to drug policy: a comment. J Illicit Econ Dev. 2020;2(1):1–9. https://doi.org/10.31389/jied.60.CrossRef

59.

Borysowski J, Górski A. Compassionate use of unauthorized drugs: Legal regulations and ethical challenges. Eur J Intern Med. 2019;1(65):12–6. https://doi.org/10.1016/j.ejim.2019.04.008.CrossRef

Title: Structural violence and the need for compassionate use of methadone in Mexico
Authors: Martha Romero-Mendoza
Ingris Peláez-Ballestas
Ariagor Manuel Almanza-Avendaño
Emilia Figueroa
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Care
Methadone
Published in: BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/s12889-022-12955-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Structural violence and the need for compassionate use of methadone in Mexico

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2022

Validation studies of verbal autopsy methods: a systematic review

Learning about COVID-19: sources of information, public trust, and contact tracing during the pandemic

Experiences of women awaiting cervical CANCER screening results from selected hospitals in Accra, Ghana

County-level associations between food retailer availability and violent crime rate

Prevalence of risk behaviors and correlates of SARS-CoV-2 positivity among in-school contacts of confirmed cases in a Georgia school district in the pre-vaccine era, December 2020–January 2021

Nutritional status, health risk behaviors, and eating habits are correlated with physical activity and exercise of brazilian older hypertensive adults: a cross-sectional study